To elucidate the potential sources of the NPV differences, it was noted that multiplex ADAP assays identified 46 out of 48 patients that progressed to stage 3 T1D as multiple islet autoantibody-positive. The gene discussed is FYB1; the disease is type 1 diabetes mellitus.